To shed some light on the potential molecular mechanisms by which LIFR-AS1 inhibits breast cancer cell proliferation, migration and invasion, we performed bioinformatics analysis and applied miRanda online software to predict the potential targets of LIFR-AS1. Here, LIFR is linked to breast carcinoma.